Insulin Resistance Is Accompanied by Increased Fasting Glucagon and Delayed Glucagon Suppression in Individuals With Normal and Impaired Glucose Regulation

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · see citing works

Glucagon-like peptide-1 7–36: a physiological incretin in man

Kreymann, B., Ghatei, M. A., Williams, G., & Bloom, S. R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91194-9 · Cited by 1,928 · see citing works

Quantification of the relationship between insulin sensitivity and β-cell function in human subjects: evidence for a hyperbolic function

Kahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes · doi:10.2337/diab.42.11.1663 · Cited by 1,405 · see citing works

Pathogenesis of type 2 diabetes mellitus

DeFronzo, R. A. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.013 · Cited by 1,342 · see citing works

Tissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans

Ørskov, C., Rabenhøj, L., Wettergren, A., Kofod, H., & Holst, J. J. (1994) · Diabetes · doi:10.2337/diab.43.4.535 · Cited by 916 · see citing works

Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients

Toft-Nielsen, M.-B., Damholt, M. B., Madsbad, S., Hilsted, L. M., Hughes, T. E., Michelsen, B. K., & Holst, J. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7750 · Cited by 869 · see citing works

Studies of pancreatic alpha cell function in normal and diabetic subjects

Unger, R. H., Aguilar-Parada, E., Müller, W. A., & Eisentraut, A. M. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106297 · Cited by 837 · see citing works

Role of Reduced Suppression of Glucose Production and Diminished Early Insulin Release in Impaired Glucose Tolerance

Mitrakou, A., Kelley, D., Mokan, M., Veneman, T., Pangburn, T., Reilly, J., & Gerich, J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201023260104 · Cited by 595 · see citing works

α-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains

Gromada, J., Franklin, I., & Wollheim, C. B. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0007 · Cited by 574 · see citing works

Validation of the insulin sensitivity index (ISI0,120): comparison with other measures

Gutt, M., Davis, C. L., Spitzer, S. B., Llabre, M. M., Kumar, M., Czarnecki, E. M., Schneiderman, N., Skyler, J. S., & Marks, J. B. (2000) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00116-3 · Cited by 464 · see citing works

Reduced Incretin Effect in Type 2 Diabetes

Knop, F. K., Vilsbøll, T., Højberg, P. V., Larsen, S., Madsbad, S., Vølund, A., Holst, J. J., & Krarup, T. (2007) · Diabetes · doi:10.2337/db07-0100 · Cited by 349 · see citing works

Relationships Between Gastric Emptying, Postprandial Glycemia, and Incretin Hormones

Marathe, C. S., Rayner, C. K., Jones, K. L., & Horowitz, M. (2013) · Diabetes Care · doi:10.2337/dc12-1609 · Cited by 335 · see citing works

Documentation of Hyperglucagonemia Throughout the Day in Nonobese and Obese Patients with Noninsulin-Dependent Diabetes Mellitus*

REAVEN, G. M., CHEN, Y.-D. I., GOLAY, A., SWISLOCKI, A. L. M., & JASPAN, J. B. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-1-106 · Cited by 326 · see citing works

GLP-1 response to oral glucose is reduced in prediabetes, screen-detected type 2 diabetes, and obesity and influenced by sex: the ADDITION-PRO study

Færch, K., Torekov, S. S., Vistisen, D., Johansen, N. B., Witte, D. R., Jonsson, A., Pedersen, O., Hansen, T., Lauritzen, T., Sandbæk, A., et al. (2015) · Diabetes · doi:10.2337/db14-1751 · Cited by 321 · see citing works

The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening

GRuttenfor the ADDITION Study Group, Lauritzen, T., Griffin, S. J., Borch‐Johnsen, K., Wareham, N., & Wolffenbuttel, B. H. R. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801420 · Cited by 247 · see citing works

Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas

de Heer, J., Rasmussen, C. E., Coy, D. H., & Holst, J. J. (2008) · Diabetologia · doi:10.1007/s00125-008-1149-y · Cited by 238 · see citing works

Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies

Åhrén, B., & Pacini, G. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500097 · Cited by 229 · see citing works

Roles of the Gut in Glucose Homeostasis

Holst, J. J., Gribble, F. M., Horowitz, M., & Rayner, C. K. (2016) · Diabetes Care · doi:10.2337/dc16-0351 · Cited by 206 · see citing works

Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus

Knop, F. K., Vilsbøll, T., Madsbad, S., Holst, J. J., & Krarup, T. (2007) · Diabetologia · doi:10.1007/s00125-006-0566-z · Cited by 191 · see citing works

Incretin Hormone and Insulin Responses to OralVersusIntravenous Lipid Administration in Humans

Lindgren, O., Carr, R. D., Deacon, C. F., Holst, J. J., Pacini, G., Mari, A., & Åhrén, B. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0266 · Cited by 188 · see citing works

Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels?

Albrechtsen, N. J. W., Hartmann, B., Veedfald, S., Windeløv, J. A., Plamboeck, A., Bojsen-Møller, K. N., Idorn, T., Feldt‐Rasmussen, B., Knop, F. K., Vilsbøll, T., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3283-z · Cited by 185 · see citing works

Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin

Holst, J. J. (1982) · Biochemical Journal · doi:10.1042/bj2070381 · Cited by 177 · see citing works

Exogenous Glucose–Dependent Insulinotropic Polypeptide Worsens Post prandial Hyperglycemia in T ype 2 Diabetes

Chia, C. W., Carlson, O. D., Kim, W., Shin, Y., Charles, C. P., Kim, H. S., Melvin, D. L., & Egan, J. M. (2009) · Diabetes · doi:10.2337/db08-0958 · Cited by 174 · see citing works

Evidence of Extrapancreatic Glucagon Secretion in Man

Lund, A., Bagger, J. I., Albrechtsen, N. J. W., Christensen, M., Grøndahl, M. F. G., Hartmann, B., Mathiesen, E. R., Hansen, C. P., Storkholm, J. H., van Hall, G., et al. (2015) · Diabetes · doi:10.2337/db15-1541 · Cited by 167 · see citing works

Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action

Færch, K., Vaag, A. A., Holst, J. J., Glümer, C., Pedersen, O. B., & Borch‐Johnsen, K. (2008) · Diabetologia · doi:10.1007/s00125-008-0951-x · Cited by 144 · see citing works

Glucagon – Early breakthroughs and recent discoveries

Åhrén, B. (2015) · Peptides · doi:10.1016/j.peptides.2015.03.011 · Cited by 126 · see citing works

The BIGTT Test

Hansen, T. F., Drivsholm, T., Urhammer, S. A., y Palacios, R. T., Vølund, A., Borch‐Johnsen, K., & Pedersen, O. B. (2007) · Diabetes Care · doi:10.2337/dc06-1240 · Cited by 104 · see citing works

Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance.

Larsson, H. E., & Åhrén, B. (2000) · Diabetes Care · doi:10.2337/diacare.23.5.650 · Cited by 96 · see citing works

Association of fasting glucagon and proinsulin concentrations with insulin resistance

Ferrannini, E., Muscelli, E., Natali, A., Gabriel, R., Mitrakou, A., Flyvbjerg, A., Golay, A., Højlund, K., & The Relationship between Insulin Sensitivity and Cardiovascular Disease Risk (RISC) Project Investigators (2007) · Diabetologia · doi:10.1007/s00125-007-0806-x · Cited by 90 · see citing works

Suppression of glucagon secretion is lower after oral glucose administration than during intravenous glucose administration in human subjects

Meier, J. J., Deacon, C. F., Schmidt, W. E., Holst, J. J., & Nauck, M. A. (2007) · Diabetologia · doi:10.1007/s00125-007-0598-z · Cited by 89 · see citing works

Molecular heterogeneity of glucagon in normal subjects and in patients with glucagon-producing tumours

Hoist, J. J. (1983) · Diabetologia · doi:10.1007/bf00251825 · Cited by 78 · see citing works

Glucose-Dependent Insulinotropic Polypeptide Is Associated With Lower Low-Density Lipoprotein But Unhealthy Fat Distribution, Independent of Insulin: The ADDITION-PRO Study

Møller, C. L., Vistisen, D., Færch, K., Johansen, N. B., Witte, D. R., Jonsson, A. E., Pedersen, O. B., Hansen, T. F., Lauritzen, T., Jørgensen, M. E., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3133 · Cited by 62 · see citing works

Protocol for ADDITION-PRO: a longitudinal cohort study of the cardiovascular experience of individuals at high risk for diabetes recruited from Danish primary care

Johansen, N. B., Bjerregaard, A., Jensen, T. M., Philipsen, A., Rasmussen, S. S., Jørgensen, M. E., Simmons, R. K., Lauritzen, T., Sandbæk, A., & Witte, D. R. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-1078 · Cited by 57 · see citing works

Incretin Effect and Glucagon Responses to Oral and Intravenous Glucose in Patients With Maturity-Onset Diabetes of the Young—Type 2 and Type 3

Østoft, S. H., Bagger, J. I., Hansen, T. F., Pedersen, O. B., Holst, J. J., Knop, F. K., & Vilsbøll, T. (2014) · Diabetes · doi:10.2337/db13-1878 · Cited by 53 · see citing works

Impact of Glucose Tolerance Status, Sex, and Body Size on Glucose Absorption Patterns During OGTTs

Færch, K., Pacini, G., Nolan, J. J., Hansen, T. F., Tura, A., & Vistisen, D. (2013) · Diabetes Care · doi:10.2337/dc13-0592 · Cited by 47 · see citing works

Glucagon secretion in relation to insulin sensitivity in healthy subjects

Åhrén, B. (2005) · Diabetologia · doi:10.1007/s00125-005-0056-8 · Cited by 40 · see citing works

Plasma glucagon suppressibility after oral glucose in obese subjects with normal and impaired glucose tolerance

Borghi, V. C., Wajchenberg, B. L., & CESAR, F. P. (1984) · Metabolism · doi:10.1016/0026-0495(84)90089-1 · Cited by 40 · see citing works

Mechanisms of Insulin Action and Insulin Resistance

Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028 · see citing works

Insulin resistance: review of the underlying molecular mechanisms

Yaribeygi, H., Farrokhi, F. R., Butler, A. E., & Sahebkar, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27603 · Cited by 929 · see citing works

Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus

Yaribeygi, H., Sathyapalan, T., Atkin, S. L., & Sahebkar, A. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8609213 · Cited by 689 · see citing works

Assessment of Insulin Secretion and Insulin Resistance in Human

Park, S. Y., Gautier, J., & Chon, S. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0220 · Cited by 301 · see citing works

Glucagon Receptor Signaling and Lipid Metabolism

Galsgaard, K. D., Pedersen, J., Knop, F. K., Holst, J. J., & Wewer Albrechtsen, N. J. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00413 · Cited by 218 · see citing works

Glucagon Receptor Signaling and Glucagon Resistance

Janah, L., Kjeldsen, S. A. S., Galsgaard, K. D., Winther‐Sørensen, M., Stojanovska, E., Pedersen, J., Knop, F. K., Holst, J. J., & Albrechtsen, N. J. W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133314 · Cited by 205 · see citing works

The Liver–α-Cell Axis and Type 2 Diabetes

Albrechtsen, N. J. W., Pedersen, J., Galsgaard, K. D., Winther‐Sørensen, M., Suppli, M. P., Janah, L., Gromada, J., Vilstrup, H., Knop, F. K., & Holst, J. J. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00251 · Cited by 149 · see citing works

The α-cell in diabetes mellitus

Gromada, J., Chabosseau, P., & Rutter, G. A. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0097-y · Cited by 143 · see citing works

The Role of Catechins in Regulating Diabetes: An Update Review

Wen, L., Wu, D., Tan, X., Zhong, M., Xing, J., Li, W., Li, D., & Cao, F. (2022) · Nutrients · doi:10.3390/nu14214681 · Cited by 121 · see citing works

Evidence of a liver–alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids

Wewer Albrechtsen, N. J., Færch, K., Jensen, T. M., Witte, D. R., Pedersen, J., Mahendran, Y., Jonsson, A. E., Galsgaard, K. D., Winther-Sørensen, M., Torekov, S. S., et al. (2018) · Diabetologia · doi:10.1007/s00125-017-4535-5 · Cited by 119 · see citing works

100 years of glucagon and 100 more

Wewer Albrechtsen, N. J., Holst, J. J., Cherrington, A. D., Finan, B., Gluud, L. L., Dean, E. D., Campbell, J. E., Bloom, S. R., Tan, T. M.-M., Knop, F. K., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-05947-y · Cited by 117 · see citing works

Glucose metabolism during rotational shift-work in healthcare workers

Sharma, A. R., LAURENTI, M. C., Man, C. D., Varghese, R. T., Cobelli, C., Rizza, R. A., Matveyenko, A. V., & Vella, A. V. (2017) · Diabetologia · doi:10.1007/s00125-017-4317-0 · Cited by 113 · see citing works

Molecular mechanisms by which GLP-1 RA and DPP-4i induce insulin sensitivity

Yaribeygi, H., Sathyapalan, T., & Sahebkar, A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116776 · Cited by 103 · see citing works

Molecular mechanisms by which aerobic exercise induces insulin sensitivity

Yaribeygi, H., Atkin, S. L., Simental‐Mendía, L. E., & Sahebkar, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28066 · Cited by 98 · see citing works

Metabolic effects of glucagon in humans

Adeva-Andany, M. M., Funcasta-Calderón, R., Fernández-Fernández, C., Castro-Quintela, E., & Carneiro-Freire, N. (2019) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2018.12.005 · Cited by 94 · see citing works

Molecular mechanisms by which SGLT2 inhibitors can induce insulin sensitivity in diabetic milieu: A mechanistic review

Yaribeygi, H., Sathyapalan, T., Maleki, M., Jamialahmadi, T., & Sahebkar, A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117090 · Cited by 94 · see citing works

Pathophysiology of Physical Inactivity-Dependent Insulin Resistance: A Theoretical Mechanistic Review Emphasizing Clinical Evidence

Yaribeygi, H., Maleki, M., Sathyapalan, T., Jamialahmadi, T., & Sahebkar, A. (2021) · Journal of Diabetes Research · doi:10.1155/2021/7796727 · Cited by 91 · see citing works

Triglyceride glucose-body mass index in identifying high-risk groups of pre-diabetes

Jiang, C., Yang, R., Kuang, M., Meng, Y., Zhong, M., & Zou, Y. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01594-7 · Cited by 91 · see citing works

Therapeutic Potential of β-Caryophyllene: A Dietary Cannabinoid in Diabetes and Associated Complications

Hashiesh, H. M., Meeran, M. F. N., Sharma, C., Sadek, B. S., Kaabi, J. A., & Ojha, S. K. (2020) · Nutrients · doi:10.3390/nu12102963 · Cited by 81 · see citing works

Antidiabetic potential of saffron and its active constituents

Yaribeygi, H., Zare, V., Butler, A. E., Barreto, G. E., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27843 · Cited by 74 · see citing works

Targeting hepatic glucokinase to treat diabetes with TTP399, a hepatoselective glucokinase activator

Vella, A. V., Freeman, J. L. R., Dunn, I. M., Keller, K., Buse, J. B., & Valcarce, C. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau3441 · Cited by 74 · see citing works

Which Role Plays 2-Hydroxybutyric Acid on Insulin Resistance?

Sousa, A. P., Cunha, D. M., Franco, C., Teixeira, C., Gojon, F., Baylina, P., & Fernandes, R. (2021) · Metabolites · doi:10.3390/metabo11120835 · Cited by 72 · see citing works

Reduced somatostatin signalling leads to hypersecretion of glucagon in mice fed a high-fat diet

Kellard, J. A., Rorsman, N. J. G., Hill, T. G., Armour, S. L., van de Bunt, M., Rorsman, P., Knudsen, J. G., & Briant, L. J. B. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101021 · Cited by 62 · see citing works

Crosstalk between autophagy and insulin resistance: evidence from different tissues

Sadeghi, A., Niknam, M., Momeni‐Moghaddam, M. A., Shabani, M., Aria, H., Bastin, A., Teimouri, M., Meshkani, R., & Akbari, H. (2023) · European journal of medical research · doi:10.1186/s40001-023-01424-9 · Cited by 65 · see citing works

Hyperglucagonemia in youth is associated with high plasma free fatty acids, visceral adiposity, and impaired glucose tolerance

Manell, H., Kristinsson, H., Kullberg, J., Ubhayasekera, S. J. K. A., Mörwald, K., Staaf, J., Cadamuro, J., Zsoldos, F., Göpel, S., Sargsyan, E., et al. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12890 · Cited by 56 · see citing works

Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseases

Sonne, N., Karsdal, M. A., & Henriksen, K. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101109 · Cited by 57 · see citing works

Recent advances in the effect of adipose tissue inflammation on insulin resistance

Yan, K. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111229 · Cited by 56 · see citing works

Disease or not, aging is easily treatable

Blagosklonny, M. V. (2018) · Aging · doi:10.18632/aging.101647 · Cited by 54 · see citing works

Role of Cannabinoid Receptor Type 1 in Insulin Resistance and Its Biological Implications

Nagappan, A., Shin, J., & Jung, M. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092109 · Cited by 56 · see citing works

Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status

Hu, C., Chen, Y., Yin, X., Xu, R., Yin, C., Wang, C., & Zhao, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02098-3 · Cited by 59 · see citing works

Effect of diet composition on insulin sensitivity in humans

Adeva-Andany, M. M., González-Lucán, M., Fernández-Fernández, C., Carneiro-Freire, N., Seco-Filgueira, M., & Pedre-Piñeiro, A. M. (2019) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2019.05.014 · Cited by 49 · see citing works

Terminalia catappa aqueous leaf extract reverses insulin resistance, improves glucose transport and activates PI3K/AKT signalling in high fat/streptozotocin-induced diabetic rats

Iheagwam, F. N., Iheagwam, O. T., Onuoha, M. K., Ogunlana, O. O., & Chinedu, S. N. (2022) · Scientific Reports · doi:10.1038/s41598-022-15114-9 · Cited by 48 · see citing works

Decreased α-cell mass and early structural alterations of the exocrine pancreas in patients with type 1 diabetes: An analysis based on the nPOD repository

Bonnet-Serrano, F., Diedisheim, M., Mallone, R., & Larger, É. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191528 · Cited by 41 · see citing works

Basal glucagon hypersecretion and response to oral glucose load in prediabetes and mild type 2 diabetes

Ichikawa, R., Takano, K., Fujimoto, K., Motomiya, T., Kobayashi, M., Kitamura, T., & Shichiri, M. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej18-0372 · Cited by 42 · see citing works

Molecular mechanisms linking stress and insulin resistance

Yaribeygi, H., Maleki, M., Butler, A. E., Jamialahmadi, T., & Sahebkar, A. (2021) · EXCLI journal · doi:10.17179/excli2021-4382 · Cited by 52 · see citing works

Nonsuppressed Glucagon After Glucose Challenge as a Potential Predictor for Glucose Tolerance

Wagner, R. J., Hakaste, L., Ahlqvist, E., Heni, M., Machann, J., Schick, F., OBBERGHEN, E. V., Stefan, N., Gallwitz, B., Tuomilehto, J., et al. (2016) · Diabetes · doi:10.2337/db16-0354 · Cited by 37 · see citing works

Impaired Insulin Action Is Associated With Increased Glucagon Concentrations in Nondiabetic Humans

Sharma, A. R., Varghese, R. T., Shah, M., Man, C. D., Cobelli, C., Rizza, R. A., Bailey, K. R., & Vella, A. V. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01197 · Cited by 34 · see citing works

Glucagon increases insulin levels by stimulating insulin secretion without effect on insulin clearance in mice

Song, G. K., Pacini, G., Åhrén, B., & D’Argenio, D. Z. (2016) · Peptides · doi:10.1016/j.peptides.2016.12.012 · Cited by 33 · see citing works

The role of spexin in energy metabolism

Sun, X., Yu, Z., Xu, Y., Pu, S., & Gao, X. (2023) · Peptides · doi:10.1016/j.peptides.2023.170991 · Cited by 32 · see citing works

Opposing effects of chronic glucagon receptor agonism and antagonism on amino acids, hepatic gene expression, and alpha cells

Elmelund, E., Galsgaard, K. D., Johansen, C. D., Trammell, S. A. J., Bomholt, A. B., Winther‐Sørensen, M., Hunt, J. E., Sørensen, C. M., Kruse, T., Lau, J. F., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105296 · Cited by 32 · see citing works

Impaired Suppression of Glucagon in Obese Subjects Parallels Decline in Insulin Sensitivity and Beta-Cell Function

Chen, X., Maldonado, E., DeFronzo, R. A., & Tripathy, D. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab019 · Cited by 31 · see citing works

The differential effect of animal versus vegetable dietary protein on the clinical manifestations of diabetic kidney disease in humans

Adeva‐Andany, M. M., Fernández‐Fernández, C., Carneiro-Freire, N., Vila-Altesor, M., & Ameneiros-Rodríguez, E. (2022) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2022.01.030 · Cited by 31 · see citing works

Ferritin and iron supplements in gestational diabetes mellitus: less or more?

Li, T., Zhang, J., & Li, P. (2023) · European Journal of Nutrition · doi:10.1007/s00394-023-03250-5 · Cited by 31 · see citing works

Assessment of individual and standardized glucagon kinetics in healthy humans

LAURENTI, M. C., Vella, A. V., Adams, J. D., Wismayer, D. S., Egan, A. M., & Man, C. D. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00488.2020 · Cited by 28 · see citing works

Altered islet prohormone processing: a cause or consequence of diabetes?

Ramzy, A., & Kieffer, T. J. (2021) · Physiological Reviews · doi:10.1152/physrev.00008.2021 · Cited by 27 · see citing works

Mathematical Model of Glucagon Kinetics for the Assessment of Insulin-Mediated Glucagon Inhibition During an Oral Glucose Tolerance Test

Morettini, M., Burattini, L., Göbl, C., Pacini, G., Ahrén, B., & Tura, A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.611147 · Cited by 27 · see citing works

Was it something I ate? Understanding the bidirectional interaction of migraine and appetite neural circuits

Martins-Oliveira, M., Tavares, I., & Goadsby, P. J. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147629 · Cited by 30 · see citing works

Fasting glucagon concentrations are associated with longitudinal decline of β-cell function in non-diabetic humans

Adams, J. D., Man, C. D., LAURENTI, M. C., Andrade, M. D. H., Cobelli, C., Rizza, R. A., Bailey, K. R., & Vella, A. V. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154175 · Cited by 26 · see citing works

Association of LDL:HDL ratio with prediabetes risk: a longitudinal observational study based on Chinese adults

Kuang, M., Peng, N., Qiu, J., Zhong, Y., Zou, Y., & Sheng, G. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01655-5 · Cited by 26 · see citing works

Insulin resistance in the retina: possible implications for certain ocular diseases

Zheng, Z., & Yu, X. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1415521 · Cited by 27 · see citing works

A Metabolomic Signature of Glucagon Action in Healthy Individuals With Overweight/Obesity

Vega, R. B., Whytock, K. L., Gassenhuber, J., Goebel, B., Tillner, J., Agueusop, I., Truax, A. D., Yu, G., Carnero, E., Kapoor, N., et al. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab118 · Cited by 24 · see citing works

Obesity and Insulin Resistance: A Review of Molecular Interactions

Yaribeygi, H., Maleki, M., Sathyapalan, T., Jamialahmadi, T., & Sahebkar, A. (2020) · Current Molecular Medicine · doi:10.2174/1566524020666200812221527 · Cited by 26 · see citing works

Emerging incretin- and multi-agonist-based treatments – the continued refinement and continuous expansion of a potent therapeutic armamentarium for cardio-kidney-liver-metabolic diseases and beyond

Muzurović, E. M., Katsiki, N., Volčanšek, Š., Plescia, F., Rizzo, M., & Mantzoros, C. S. (2026) · Metabolism · doi:10.1016/j.metabol.2026.156494 · Cited by 24 · see citing works

Metabolic Phenotypes and Step by Step Evolution of Type 2 Diabetes: A New Paradigm

Cooper, I. D., Brookler, K. H., Kyriakidou, Y., Elliott, B., & Crofts, C. A. P. (2021) · Biomedicines · doi:10.3390/biomedicines9070800 · Cited by 23 · see citing works

Plasma glucagon levels measured by sandwich ELISA are correlated with impaired glucose tolerance in type 2 diabetes

Kobayashi, M., Satoh, H., Matsuo, T., Kusunoki, Y., Tokushima, M., Watada, H., Namba, M., & Kitamura, T. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej20-0079 · Cited by 23 · see citing works

Differential contribution of alpha and beta cell dysfunction to impaired fasting glucose and impaired glucose tolerance

Kohlenberg, J. D., LAURENTI, M. C., Egan, A. M., Wismayer, D. S., Bailey, K. R., Cobelli, C., Man, C. D., & Vella, A. V. (2022) · Diabetologia · doi:10.1007/s00125-022-05794-3 · Cited by 22 · see citing works

Prolactin regulatory element-binding (PREB) protein regulates hepatic glucose homeostasis

Park, J.-M., Kim, M., Kim, T. H., Min, D., Yang, G. E., & Ahn, Y. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.03.024 · Cited by 22 · see citing works

Hyperglucagonaemia in diabetes: altered amino acid metabolism triggers mTORC1 activation, which drives glucagon production

Riahi, Y., Kogot‐Levin, A., Kadosh, L., Agranovich, B., Malka, A., Assa, M., Piran, R., Avrahami, D., Gläser, B., Gottlieb, E., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-05967-8 · Cited by 19 · see citing works

The Importance of Intra-Islet Communication in the Function and Plasticity of the Islets of Langerhans during Health and Diabetes

Hill, T. G., & Hill, D. J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25074070 · Cited by 20 · see citing works

Hyperglucagonemia Does Not Explain the β-Cell Hyperresponsiveness and Insulin Resistance in Dysglycemic Youth Compared With Adults: Lessons From the RISE Study

Kahn, S. E., Mather, K. J., Arslanian, S. A., Barengolts, E., Buchanan, T. A., Caprio, S., Ehrmann, D. A., Hannon, T. S., Marcovina, S. M., Nadeau, K. J., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0460 · Cited by 20 · see citing works

Impact of glucagon response on early postprandial glucose excursions irrespective of residual β‐cell function in type 1 diabetes: A cross‐sectional study using a mixed meal tolerance test

Ito, A., Horie, I., Miwa, M., Sako, A., Niri, T., Nakashima, Y., Shigeno, R., Haraguchi, A., Natsuda, S., Akazawa, S., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13486 · Cited by 19 · see citing works

The human α cell in health and disease

Pettway, Y. D., Saunders, D. C., & Briššová, M. (2023) · Journal of Endocrinology · doi:10.1530/joe-22-0298 · Cited by 20 · see citing works

A longitudinal study on the impact of the TyG Index and TG/HDL-C ratio on the risk of type 2 diabetes in Chinese patients with prediabetes

Chen, B., Zeng, J., Fan, M., You, Q., Wang, C., Wang, K., Qin, M., & Xu, S. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02239-1 · Cited by 19 · see citing works

Glucose kinetics

Gastaldelli, A., Gaggini, M., & DeFronzo, R. A. (2017) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000384 · Cited by 19 · see citing works

Postprandial Suppression of Glucagon Secretion: A Puzzlement

Geary, N. (2017) · Diabetes · doi:10.2337/dbi16-0075 · Cited by 19 · see citing works

β Cell GHS-R Regulates Insulin Secretion and Sensitivity

Pradhan, G., Wu, C., Villarreal, D., Lee, J. H., Han, H. W., Gaharwar, A. K., Tian, Y., Fu, W., Guo, S., Smith, R. G., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083950 · Cited by 19 · see citing works

Patterns of plasma glucagon dynamics do not match metabolic phenotypes in young women

Gar, C., Rottenkolber, M., Sacco, V., Moschko, S., Banning, F., Hesse, N., Popp, D., Hübener, C., Seissler, J., & Lechner, A. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02014 · Cited by 18 · see citing works

Diabetes Mellitus in Pancreatic Cancer: A Distinct Approach to Older Subjects with New-Onset Diabetes Mellitus

Bureš, J., Kohoutová, D., Škrha, J., Bunganič, B., Ngo, O., Suchánek, Š., Škrha, P., & Zavoral, M. (2023) · Cancers · doi:10.3390/cancers15143669 · Cited by 19 · see citing works

High fat diet is associated with gut microbiota dysbiosis and decreased gut microbial derived metabolites related to metabolic health in young Göttingen Minipigs

Lützhøft, D. O., Bækgård, C., Wimborne, E. A., Straarup, E. M., Pedersen, K., Swann, J. R., Pedersen, H. D., Kristensen, K., Morgills, L., Nielsen, D. S., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0298602 · Cited by 18 · see citing works

Relationship Between Fasting Plasma Glucagon Level and Renal Function—A Cross-Sectional Study in Individuals With Type 2 Diabetes

Liu, J., Liu, S., Gurung, R. L., Chan, C., Ang, K., Tang, W. E., Subramaniam, T., Sum, C. F., & Lim, S. C. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00321 · Cited by 18 · see citing works

Zbtb7c is a critical gluconeogenic transcription factor that induces glucose-6-phosphatase and phosphoenylpyruvate carboxykinase 1 genes expression during mice fasting

Choi, W., Yoon, J.-H., Song, J.-Y., Jeon, B., Park, J.-M., Koh, D., Ahn, Y., Kim, K., Lee, I. K., & Hur, M. (2019) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2019.04.001 · Cited by 18 · see citing works

Ugonin J improves metabolic disorder and ameliorates nonalcoholic fatty liver disease by regulating the AMPK/AKT signaling pathway

Chang, T.-C., Chiou, W.-C., Lai, W.-H., Huang, H., Huang, Y., Liu, H., Liang, Y., & Huang, C. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105298 · Cited by 18 · see citing works

Alteration of the Individual Metabolic Network of the Brain Based on Jensen-Shannon Divergence Similarity Estimation in Elderly Patients With Type 2 Diabetes Mellitus

Li, Y., Wu, J., Ma, J., Li, S., Xue, X., Dong, W., Shan, C., Hua, X., Zheng, M., & Xu, J. (2022) · Diabetes · doi:10.2337/db21-0600 · Cited by 18 · see citing works

Pancreatic α‐cell mass in obesity

Ellenbroek, J. H., Töns, H. A. M., Hanegraaf, M. A. J., Rabelink, T. J., Engelse, M. A., Carlotti, F., & de Koning, E. J. P. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12997 · Cited by 17 · see citing works

Nonlinear relationship between aspartate aminotransferase to alanine aminotransferase ratio and the risk of prediabetes: A retrospective study based on chinese adults

Cao, C., Zhang, X., Yuan, J., Zan, Y., Zhang, X., Xue, C., Wang, Y., & Zheng, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1041616 · Cited by 16 · see citing works

A newly developed glucagon sandwich ELISA is useful for more accurate glucagon evaluation than the currently used sandwich ELISA in subjects with elevated plasma proglucagon‐derived peptide levels

Kobayashi, M., Maruyama, N., Yamamoto, Y., Togawa, T., Ida, T., Yoshida, M., Miyazato, M., Kitada, M., Hayashi, Y., Kashiwagi, A., et al. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.13986 · Cited by 16 · see citing works

β-Sitosterol Glucoside-Loaded Nanosystem Ameliorates Insulin Resistance and Oxidative Stress in Streptozotocin-Induced Diabetic Rats

Afifi, S. M., Ammar, N. M., Kamel, R., Esatbeyoglu, T., & Hassan, H. A. (2022) · Antioxidants · doi:10.3390/antiox11051023 · Cited by 16 · see citing works

In vitro and in vivo study of inhibitory potentials of α-glucosidase and acetylcholinesterase and biochemical profiling of M. charantia in alloxan-induced diabetic rat models.

Hussain, F., Hafeez, J., Khalifa, A. S., Naeem, M., Ali, T., & Eed, E. M. (2022) · PubMed Central · Cited by 16 · see citing works

Diabetes Mellitus: The Pathophysiology as a Canvas for Management Elucidation and Strategies

Iheagwam, F., & Iheagwam, O. T. (2025) · Medicine in Novel Technology and Devices · doi:10.1016/j.medntd.2025.100351 · Cited by 20 · see citing works

Expected values for gastrointestinal and pancreatic hormone concentrations in healthy volunteers in the fasting and postprandial state

Meek, C. L., Lewis, H. B., Burling, K., Reimann, F. M., & Gribble, F. M. (2020) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563220975658 · Cited by 15 · see citing works

A Hepatocyte FOXN3-α Cell Glucagon Axis Regulates Fasting Glucose

Karanth, S., Adams, J. D., Serrano, M. D. L. Á., Quittner-Strom, E. B., Simcox, J., Villanueva, C. J., Özcan, L., Holland, W. L., Yost, H. J., Vella, A. V., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.039 · Cited by 15 · see citing works

The glucose-mobilizing effect of glucagon at fasting is mediated by cyclic AMP

Albrechtsen, N. J. W. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00172.2021 · Cited by 15 · see citing works

The Role of Glucagon in Glycemic Variability in Type 1 Diabetes: A Narrative Review

Guo, K., Tian, Q., Yang, L., & Zhou, Z. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s343514 · Cited by 17 · see citing works

Positive correlation between fasting plasma glucagon and serum C-peptide in Japanese patients with diabetes

Hosokawa, Y., Kozawa, J., Nishizawa, H., Kawamori, D., Maeda, N., Otsuki, M., Matsuoka, T., Iwahashi, H., & Shimomura, I. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e01715 · Cited by 15 · see citing works

Could Polyphenolic Food Intake Help in the Control of Type 2 Diabetes? A Narrative Review of the Last Evidence

D’Angelo, S., Ferrara, L., & Joksimović, M. (2022) · Current Nutrition & Food Science · doi:10.2174/1573401318666220317140717 · Cited by 14 · see citing works

Opportunities and challenges: interleukin-22 comprehensively regulates polycystic ovary syndrome from metabolic and immune aspects

Geng, Y., Liu, Z., Hu, R., Ma, W., Wu, X., Dong, H., Song, K., Xu, X., Huang, Y., Li, F., et al. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01236-9 · Cited by 14 · see citing works

Association between osteocalcin, a pivotal marker of bone metabolism, and secretory function of islet beta cells and alpha cells in Chinese patients with type 2 diabetes mellitus: an observational study

Lei, H., Liu, J., Wang, W., Yang, X., Feng, Z., Zang, P., Lu, B., & Shao, J. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00932-8 · Cited by 14 · see citing works

Effects of Moderate Chronic Food Restriction on the Development of Postprandial Dyslipidemia with Ageing

Fernández, A., Mazuecos, L., Pintado, C., Rubio, B., López, V., Solís, A. J. D., Rodríguez-Pérez, M., Andrés, A., & Gallardo, N. (2019) · Nutrients · doi:10.3390/nu11081865 · Cited by 13 · see citing works

Altered Glucagon and GLP-1 Responses to Oral Glucose in Children and Adolescents With Obesity and Insulin Resistance

Stinson, S. E., Alzola, I. F. D. R., Hovendal, E. D. B., Lund, M. A. V., Fonvig, C. E., Holm, L. A., Jonsson, A. E., Frithioff‐Bøjsøe, C., Christiansen, M., Pedersen, O. B., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad728 · Cited by 12 · see citing works

Blockade of glucagon receptor induces α-cell hypersecretion by hyperaminoacidemia in mice

Jia, J., Bai, X., Kang, Q., Jiang, F., Wong, F. S., Jin, Q., & Li, M. (2025) · Nature Communications · doi:10.1038/s41467-025-57786-7 · Cited by 13 · see citing works

Robust increase in glucagon secretion after oral protein intake, but not after glucose or lipid intake in Japanese people without diabetes

Ichikawa, R., Takano, K., Fujimoto, K., Kobayashi, M., Kitamura, T., Shichiri, M., & Miyatsuka, T. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14053 · Cited by 13 · see citing works

Insulin-like growth factor-1 is a negative modulator of glucagon secretion

Mancuso, E., Mannino, G. C., Fatta, C. D., Fuoco, A., Spiga, R., Andreozzi, F., & Sesti, G. (2017) · Oncotarget · doi:10.18632/oncotarget.18514 · Cited by 13 · see citing works

Lower serum zinc level is associated with higher fasting insulin in type 2 diabetes mellitus (T2DM) and relates with disturbed glucagon suppression response in male patients.

Safarzad, M., Jazi, M. S., Kiaei, M., & Asadi, J. (2023) · Primary Care Diabetes · doi:10.1016/j.pcd.2023.05.008 · Cited by 13 · see citing works

Exposure to Aroclor 1254 differentially affects the survival of pancreatic β-cells and α-cells in the male mice and the potential reason

Fang, L., Zhang, S., Ou, K., Zuo, Z., Yu, A., & Wang, C. (2019) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2019.109875 · Cited by 12 · see citing works

Mechanisms behind the anti-diabetic and anti-obesity effects of seaweeds or macroalgae and their bioactive compounds

Magwaza, S. N., & Islam, M. S. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i11.112847 · Cited by 11 · see citing works

Inadequate Glucagon Suppression During OGTT in Prediabetes: A Systematic Review and Meta-analysis

Chang, L., Liu, Y., Gu, Y., Yan, S., Ding, L., Liu, M. R., & He, Q. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae460 · Cited by 11 · see citing works

Effect of Pancreatic Hormones on pro-Atrial Natriuretic Peptide in Humans

Zois, N. E., Terzic, D., Færch, K., Plomgaard, P., Hansen, J. S., Rossing, P. R., & Goetze, J. P. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.02.026 · Cited by 11 · see citing works

Whey Protein Supplementation Improves the Glycemic Response and May Reduce Non-Alcoholic Fatty Liver Disease Related Biomarkers in Women with Polycystic Ovary Syndrome (PCOS)

Zumbro, E. L., Rao, M., Balcom-Luker, S., Broughton, K. S., & LeMieux, M. J. (2021) · Nutrients · doi:10.3390/nu13072451 · Cited by 11 · see citing works

Glucagon is associated with NAFLD inflammatory progression in type 2 diabetes, not with NAFLD fibrotic progression

Wang, Y., Lin, Z., Wan, H., Zhang, W., Xia, F., Chen, Y., Chen, X., Wang, C., Chen, C., Wang, N., et al. (2021) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002269 · Cited by 11 · see citing works

Contribution of pancreatic α‐cell function to insulin sensitivity and glycemic variability in patients with type 1 diabetes

Takahashi, N., Chujo, D., Kajio, H., & Ueki, K. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12949 · Cited by 10 · see citing works

Glucose Suppression of Glucagon: Relationship to Pancreatic Beta Cell Function?

Hatfield, H. H., BANASIAK, M. F., DRISCOLL, T., Kim, H., & Kalkhoff, R. K. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-44-6-1080 · Cited by 21 · see citing works

Plasma glucagon suppressibility after oral glucose in obese subjects with normal and impaired glucose tolerance

Borghi, V. C., Wajchenberg, B. L., & CESAR, F. P. (1984) · Metabolism · doi:10.1016/0026-0495(84)90089-1 · Cited by 40 · see citing works

Impaired Suppression of Glucagon in Obese Subjects Parallels Decline in Insulin Sensitivity and Beta-Cell Function

Chen, X., Maldonado, E., DeFronzo, R. A., & Tripathy, D. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab019 · Cited by 31 · see citing works

Hyperglucagonemia and impaired insulin sensitivity are associated with development of prediabetes and type 2 diabetes - A study from South India

Kumpatla, S., Parveen, R., Murugan, P., Juttada, U., Devarajan, A., & Viswanathan, V. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.102199 · Cited by 7 · see citing works

Altered glucose-dependent secretion of glucagon and ACTH is associated with insulin resistance, assessed by population analysis

Eriksson, J. W., Emad, R. A., Lundqvist, M., Abrahamsson, N., & Kjellsson, M. C. (2023) · Endocrine Connections · doi:10.1530/ec-22-0506 · Cited by 11 · see citing works